Gastrointestinal toxicity of antibody-drug conjugates (ADCs) in metastatic breast cancer: A pooled analysis

被引:0
|
作者
di Mauro, Pierluigi
Pedersini, Rebecca
Petrelli, Fausto
Ghidini, Antonio
Amoroso, Vito
Laini, Lara
Parati, Maria Chiara
Bossi, Paolo
Berruti, Alfredo
机构
关键词
D O I
10.1158/1538-7445.SABCS21-P5-18-15
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P5-18-15
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Antibody-drug conjugates for breast cancer: a bibliometric study and clinical trial analysis
    Xing, Mengjie
    Li, Zhiyi
    Cui, Yuwan
    He, Minghua
    Xing, Yang
    Yang, Lei
    Liu, Ziling
    Luo, Linzhi
    Wang, Hong
    Guo, Rui
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [42] Activity of antibody-drug conjugates (ADCs) with radiation in preclinical bladder cancer models.
    D'Andrea, Vincent
    Zhou, Yuzhen
    Shanmugam, Surish
    Chroneos, Rea
    Stelter, Isabella
    Hanlon, Timothy
    Bekele, Raie
    Anderson, William
    Carvalho, Filipe L. F.
    Bellmunt, Joaquim
    Mouw, Kent William
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 664 - 664
  • [43] Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer
    Shastry, Mythili
    Jacob, Saya
    Rugo, Hope S.
    Hamilton, Erika
    BREAST, 2022, 66 : 169 - 177
  • [44] Last but not least: antibody-drug conjugates in hormone receptor-positive metastatic breast cancer
    Stecklein, S. R.
    Sharma, P.
    ANNALS OF ONCOLOGY, 2020, 31 (12) : 1594 - 1596
  • [45] Antibody-drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (I)
    Wang, Peng-Hui
    Liu, Chia-Hao
    Yang, Szu-Ting
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2024, 63 (06): : 817 - 819
  • [46] Radiotherapy and novel antibody-drug conjugates in breast cancer patients
    Ippolito, Edy
    Benincasa, Martina
    Silipigni, Sonia
    Infante, Jessica
    Donato, Marco
    Pantano, Francesco
    Fiore, Michele
    Greco, Carlo
    Molfese, Elisabetta
    Di Donato, Alessia
    Sciommari, Cecilia
    Carnevale, Alessia
    Tonini, Giuseppe
    Ramella, Sara
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S677 - S679
  • [47] Resistance to antibody-drug conjugates in breast cancer: mechanisms and solutions
    Chen, Yu-Fei
    Xu, Ying-ying
    Shao, Zhi-Ming
    Yu, Ke-Da
    CANCER COMMUNICATIONS, 2023, 43 (03) : 297 - 337
  • [48] The evolving therapeutic landscape of antibody-drug conjugates in breast cancer
    Chen, Nan
    Michaels, Elena
    Howard, Frederick
    Nanda, Rita
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (12) : 1325 - 1331
  • [49] Future potential targets of antibody-drug conjugates in breast cancer
    Corti, Chiara
    Bielo, Luca Boscolo
    Schianca, Ambra Carnevale
    Salimbeni, Beatrice Taurelli
    Criscitiello, Carmen
    Curigliano, Giuseppe
    BREAST, 2023, 69 : 312 - 322
  • [50] Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer
    Saltalamacchia, Giuseppe
    Torrisi, Rosalba
    De Sanctis, Rita
    Masci, Giovanna
    Miggiano, Chiara
    Gaudio, Mariangela
    Benvenuti, Chiara
    Jacobs, Flavia
    Gerosa, Riccardo
    Santoro, Armando
    Zambelli, Alberto
    BIOMEDICINES, 2024, 12 (03)